Revance Therapeutics | RVNC - Ordinary Share Capital

Revance Therapeutics reported $82K in Ordinary Share Capital for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ordinary Share Capital Change
Cara Therapeutics CARA:US USD 53K 0
Coherus Biosciences CHRS:US USD 8K 1000
Endo International Ordinary Shares ENDP:US USD 63K 3K
Horizon Pharma HZNP:US USD 23K 0
JAZZ PHA JAZZ:US USD 61K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Pacira Pharmaceuticals PCRX:US USD 46K 0
Procter & Gamble PG:US USD 4.01B 0
Revance Therapeutics RVNC:US USD 82K 0
Supernus Pharmaceuticals SUPN:US USD 54K 0
Teva Pharmaceutical Industries TEVA:US USD 57M 0